FDA Investigator Richard L Bartlett
Richard L Bartlett has inspections in 1 countries as of 08 Mar 2024. Richard L Bartlett has collaborated with a combined 1037 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
08 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Albert F Peacock, PhD,
Alice A Blair,
Amanda B Athey,
Amanda J White,
Angel K Sandhu,
Anthony E Keller, RPh,
Brent T Hall,
Brent W Higgs,
Bryce A May,
Candace S Tucker,
Cody D Rickman,
David L Miser,
Deborah Kleinfeld,
Decarlos A Gomez,
Edward D Harris,
Elmina E Akwo,
Elmina E Mboh,
Emily B Camire,
Eric T Huebler,
Gabriel M Guevarra,
Gene D Arcy,
Helen J Hamaoka,
Henry E Sanchez,
Herbert E Arden,
Jeffrey M Watson,
Jude C Dikes,
Ka L Wong,
Kaarin M Slotte,
Karen J Bak,
Kelly D Moore,
Kip J Hanks,
Lauren M Lilly, PhD,
Laurissa S Flowers,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Maira P Brading,
Marion W Nadeau,
Mark E Baldwin,
Mark E Chan,
Matthew J Gretkierewicz,
Michael Davila,
Michael R Goga,
Nicholas M Smith,
Patricia M Jacobs,
Ramon L Gonzalez Prieto,
Rebecca T Davis,
Roberta K Smith,
Roger D Gawne,
Ronda R Loyd Jones,
Seyyida Saterfield,
Shelley H Beausoleil,
Sherri J Jackson,
Stuart W Russell,
Tania Y Hall,
Timothy P Lafave,
Victoria V Bot,
William F Lagud, Jr,
William J Foust,
Yaw O Osei,
Young M Yoon,
Yvonne C Wilkes
Richard L Bartlett's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2022 | FDA 483 | Vitalant - Form 483, 2022-05-02 |
March, 2023 | FDA 483 | UCSF Health - Pediatric Cellular Therapy Laboratory - Form 483, 2023-03-21 |
February, 2023 | FDA 483 | Laurel Fertility Care, A Professional Medical Corporation - Form 483, 2023-02-07 |
October, 2022 | FDA 483 | UCSF Medical Center Clinical Laboratories Transfusion Service at Mission Bay - Form 483, 2022-10-17 |
September, 2023 | FDA 483 | Elutia Inc. - Form 483, 2023-09-25 |
February, 2022 | FDA 483 | Vitalant - Form 483, 2022-02-18 |
January, 2024 | FDA 483 | Cbr Systems Inc - Form 483, 2024-01-17 |
March, 2024 | FDA 483 | Frontier Biologics LLC - Form 483, 2024-03-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more